Literature DB >> 11345979

American Academy of Pediatrics. Committee on Nutrition. Soy protein-based formulas: recommendations for use in infant feeding.

.   

Abstract

The American Academy of Pediatrics is committed to the use of maternal breast milk as the ideal source of nutrition for infant feeding. Even so, by 2 months of age, most infants in North America are formula-fed. Despite limited indications, the use of soy protein-based formula has nearly doubled during the past decade to achieve 25% of the market in the United States. Because an infant formula provides the largest, if not sole, source of nutrition for an extended interval, the nutritional adequacy of the formula must be confirmed and the indications for its use well understood. This statement updates the 1983 Committee on Nutrition review and contains some important recommendations on the appropriate use of soy protein-based formulas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11345979

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  28 in total

Review 1.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-08

2.  Dietary manipulations for infantile colic.

Authors: 
Journal:  Paediatr Child Health       Date:  2003-09       Impact factor: 2.253

3.  Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula.

Authors:  Haibo Xu; Ratheishan Rajesan; Patricia Harper; Richard B Kim; Bo Lonnerdal; Mingdong Yang; Satoko Uematsu; Janine Hutson; Jo Watson-MacDonell; Shinya Ito
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

4.  The phytoestrogen genistein induces thymic and immune changes: a human health concern?

Authors:  Srikanth Yellayi; Afia Naaz; Melissa A Szewczykowski; Tomomi Sato; Jeffrey A Woods; Jongsoo Chang; Mariangela Segre; Clint D Allred; William G Helferich; Paul S Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Types of Infant Formulas Consumed in the United States.

Authors:  Lauren M Rossen; Alan E Simon; Kirsten A Herrick
Journal:  Clin Pediatr (Phila)       Date:  2015-07-06       Impact factor: 1.168

6.  Soy-based diet exacerbates seizures in mouse models of neurological disease.

Authors:  Cara J Westmark; Pamela R Westmark; James S Malter
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula.

Authors:  Yang Cao; Antonia M Calafat; Daniel R Doerge; David M Umbach; Judy C Bernbaum; Nathan C Twaddle; Xiaoyun Ye; Walter J Rogan
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-07-30       Impact factor: 5.563

8.  Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein.

Authors:  Wan-Yee Tang; Retha Newbold; Katerina Mardilovich; Wendy Jefferson; Robert Y S Cheng; Mario Medvedovic; Shuk-Mei Ho
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

9.  The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy.

Authors:  M Reche; C Pascual; A Fiandor; I Polanco; M Rivero-Urgell; R Chifre; S Johnston; M Martín-Esteban
Journal:  Pediatr Allergy Immunol       Date:  2010-03-10       Impact factor: 6.377

10.  Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants.

Authors:  Carol Lynn Berseth; Susan Hazels Mitmesser; Ekhard E Ziegler; John D Marunycz; Jon Vanderhoof
Journal:  Nutr J       Date:  2009-06-19       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.